← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Western Ontario
London, ON
$17,742,917
Total funding
26
Grants
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,427,393 · 17
DOD$4,463,564 · 7
NASA$1,851,960 · 2
By mechanism
—$6,315,524 · 9
R01$6,290,307 · 6
U01$2,787,105 · 1
UH3$648,000 · 1
R33$621,101 · 1
R21$442,550 · 2
Investigators at University Of Western Ontario
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Hyperpolarized 13C MRI of Placental Metabolic Abnormalities Resulting from the Western Diet$2,787,105
U01 · FY2015 · HD
NEXT-GENERATION HUMANIZED MICE TO INVESTIGATE HOW TBI INTERACTS WITH GENETIC RISK FACTORS TO TRIGGER DEMENTIA.$1,261,840
· FY2020 · Defense Health Agency
ADVANCED DEVELOPMENT OF A THERAPEUTIC HUMANIZED ANTI-INFLAMMATORY ANTIBODY$1,077,921
· FY2010 · Department of Defense
IMPROVING OUR UNDERSTANDING OF THE NEAR-EARTH METEOROID ENVIRONMENT IS VITAL TO THE SAFETY AND SURVIVABILITY OF NASA SPACECRAFT. RISK ASSESSMENTS FOR$1,016,960
· FY2014 · National Aeronautics and Space Administration
MONITORING AND MODELING OF THE METEOROID ENVIRONMENT IS VITAL TO THE SAFETY AND SURVIVABILITY OF SPACECRAFT. ENGINEERING DESIGN OF SPACECRAFT TO MITI$835,000
· FY2015 · National Aeronautics and Space Administration
TARGETING LUNG-DERIVED PROTEINS AS A THERAPEUTIC STRATEGY AGAINST BREAST CANCER METASTASIS$810,417
· FY2017 · Department of the Army
CHARACTERIZING THE AGGRESSIVENESS OF PROSTATE CANCER WITH MULTIMODALITY IMAGING$730,536
· FY2019 · Defense Health Agency
Viral and host factors in neuroinvasion of encephalitis alphaviruses$521,574
R01 · FY2024 · AI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$521,574
R01 · FY2025 · AI
ADVANCED DEVELOPMENT OF A THERAPEUTIC, HUMANIZED, ANTI-INFLAMMATORY ANTIBODY$479,646
· FY2010 · Department of Defense
Determinants of HIV transmission fitness$411,631
R01 · FY2023 · AI
Determinants of HIV transmission fitness$411,631
R01 · FY2024 · AI
Determinants of HIV transmission fitness$411,631
R01 · FY2022 · AI
Determinants of HIV transmission fitness$411,631
R01 · FY2021 · AI
Determinants of HIV transmission fitness$411,631
R01 · FY2020 · AI
Impact of HIV-1 fitness on disease progression$348,987
R01 · FY2015 · AI
Impact of HIV-1 fitness on disease progression$347,410
R01 · FY2014 · AI
Impact of HIV-1 fitness on disease progression$343,027
R01 · FY2016 · AI
Non-Invasive Monitoring of CRISPR/Cas-Edited Chimeric Antigen Receptor T (CAR-T) Cells with Reporter Gene-Based Magnetic Resonance Imaging and Positron Emission Tomography$324,000
UH3 · FY2022 · EB
Non-Invasive Monitoring of CRISPR/Cas-Edited Chimeric Antigen Receptor T (CAR-T) Cells with Reporter Gene-Based Magnetic Resonance Imaging and Positron Emission Tomography$324,000
UH3 · FY2021 · EB